Masitinib Inhibits the Replication of SARS-CoV-2 in Preclinical Models
technologynetworks.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from technologynetworks.com Daily Mail and Mail on Sunday newspapers.
Remédio usado em cães é aposta de pesquisadores para tratar covid-19
correiobraziliense.com.br - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from correiobraziliense.com.br Daily Mail and Mail on Sunday newspapers.
Remédio usado em cachorros é a aposta de pesquisadores para tratar COVID-19
em.com.br - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from em.com.br Daily Mail and Mail on Sunday newspapers.
Existing drug may be effective in treating COVID-19
A new University of Chicago study has found that the drug masitinib may be effective in treating COVID-19.
The drug, which has undergone several clinical trials for human conditions but has not yet received approval to treat humans, inhibited the replication of SARS-CoV-2 in human cell cultures and in a mouse model, leading to much lower viral loads.
Researchers at UChicago s Pritzker School of Molecular Engineering (PME), working with collaborators at Argonne National Laboratory and around the world, also found that the drug could be effective against many types of coronaviruses and picornaviruses. Because of the way it inhibits replication, it has also been shown to remain effective in the face of COVID-19 variants.